References
- London W T. Primary hepatocellular carcinoma-etiology, pathogenesis, and prevention. Human Pathol 1981; 12: 1085–1097
- Beasley R P. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations. Hepatology 1982; 2: 21S–26S
- Sondik E J., Young J L., Horm J W., et al. 1986 Annual Cancer Statistics Review. Division of Cancer Prevention and Control. NCI, Bethesda Maryland 1986
- Tang Z-Y. Prognosis of hepatocellular carcinoma and factors influencing it. Subclinical Hepatocellular Carcinoma, Z-Y Tang. Beijing, China Academic Publishers, Berlin Springer-Verlag 1985; 179–188
- WHO. Report of WHO meeting. Prevention of liver cancer. WHO Technical, Geneva 1983, Series 691
- Blumberg B S., London W T. Hepatitis B virus and the prevention of primary cancer of the liver. Editorial. J Natal Cancer Inst 1985; 74: 267–273
- Iljima I, Saitoh N, Nobutomo K, et al. A prospective cohort study of hepatitis B surface antigen carriers in a working population. Gann 1984; 75: 571–573
- Heyward W L., Lanier A P., McMahon B J., et al. Early detection of primary hepatocellular carcinoma by screening for alpha fetoprotein among persons infected with hepatitis B virus. JAMA 1985; 254: 3052–3054
- Beasley R P., Hwang L-Y. Epidemiology of hepatocellular carcinoma. Viral Hepatitis and Liver Disease, G N. Vyas, J L. Dienstag, J H. Hoomagle, F L. Orlando. Grune & Stratton, Inc., Orlando 1984; 209–224
- Farber E, Cameron R. The sequential analysis of cancer development. Adv Cancer Res 1980; 31: 125–226
- Beasley R P., Shiao I-S, Wu T-C, et al. Hepatoma in an HBsAg carrier-seven years after perinatal infection. J Pediatr 1982; 101: 83–84
- Popper H, Roth L, Purcell R H., et al. Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci (USA) 1987; 84: 866–870
- Brechot C, Hadchouel M, Scotto J, et al. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci (USA) 1981; 73: 3906–3910
- Shafrirz D, Shouval D, Sherman H I., et al. Integration of hepatitis B virus DNA into the genome of the liver cells in chronic liver disease and hepatocellular carcinoma; studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med 1981; 303: 1067–1073
- Moriarty A M., Alexander H, Lemer R A., et al. Antibodies to peptides detect new hepatitis B antigen; serological correlation with hepatocellular carcinoma. Science 1985; 227: 429–433
- Meyers M L., Trepo L V., Nath N, et al. Hepatitis B virus polypeptide X: Expression in Escherichia coli and identification of specific antibodies is sera from hepatitis B virus-infected humans. J Virol 1986; 57: 101–109
- Yolcosuka O, Omata M, Imazeki F, et al. Hepatitis B virus RNA transcripts and DNA in chronic liver disease. N Engl J Med 1986; 315: 1187–1192
- Neel B G., Heyward W S., Robinson H L., et al. Avian leukosis virus induced tumors have common proviral integration sites and synthesize descrete new RNAs containing viral and cellular information: oncogenesis by promoter insertion. Cell 1981; 23: 323–334
- Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489–495
- Shaul Y, Rutter W J., Laub O. A human hepatitis B viral enhancer element. EMBO J 1985; 4: 427–430
- Kaneko S, Kodama K, Hattori N, et al. A small part of wood-chuck hepatitis virus genome corresponding to the enhancer region is stably integrated in a hepatoma cell line of woodchuck. J Virol, in press
- Ochiya T, Fujiyama A, Fukushige S, et al. Molecular cloning of an oncogene from a human hepatocellular carcinoma. Proc Natl Acad Sci (USA) 1986; 83: 4993–4997
- Rogler C E., Sherman M, Su C Y. Deletion in chromosome lip associated with a hepatitis B integration site in hepatocellular carcinoma. Science 1985; 230: 319–322
- Wang H P., Rogler C E. Deletion of the distal region of chromosome 11p in hepatocellular carcinomas from HBV carriers. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1986; 53, Abstracts of Molecular Biology of Hepatitis B viruses, August 28–31, 1986
- Su S Y., Fu X-X, Lee Y I., et al. Activation of insulin-like growth factor II transcription in primary HCC from WHV carriers. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1986, Abstracts of Molecular Biology of Hepatitis B Viruses, August 28–31, 1986
- Knudson A G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci (USA) 1971; 68: 820–823
- Knudson A G. Mutation and human cancer. Adv Cancer Res 1973; 17: 317–352
- Godbout R, Dryja T P., Squire J, et al. Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma. Nature 1983; 304: 451–453
- Cavenee W K., Dryja T P., Phillips R A., et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983; 305: 779–784
- Dryja T P., Cavenee W, White R, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. N Engl J Med 1984; 310: 550–553
- Friend S H., Bernards S R., Rojelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–646
- Lee W-H, Bookstein R, Hong F, et al. Human retinoblastoma susceptibility gene: cloning, identification and sequence. Science 1987; 235: 1394–1399
- Smith M, Hiroshige S, Murray J. Evidence in human hepatomas for structural chromosome changes and alteration in the expression of genes in the region 4q21–4q27. Am J Hum Genet 1986; 39: A220
- Buetow K H., Murray J C., Redeker A, Govindarajan S, London W T. Loss of heterozygosity in primary hepatocellular carcinoma (PHC) suggest recessive oncogene on chromosome 4q. Am J Hum Genet 1987; 41: A24
- London W T., Blumberg B S. A cellular model of the role of hepatitis B virus in the pathogenesis of primary hepatocellular carcinoma. Hepatology 1982; 2: 10S–14S